Keliomics

🎊 Exciting News! We are thrilled to welcome Dr. Smriti Agrawal, Ph.D. as Co-Founder and Chief Commercial Officer at Keliomics! Dr. Agrawal brings a remarkable background that aligns closely with Keliomics’ mission of revolutionizing #drugdiscovery by creating organ-scale models that mimic human biology with unparalleled precision. By accelerating drug development through our technology, Keliomics aims to reduce the time and cost of bringing safe, effective treatments to patients. Dr. Agrawal’s background in innovative biotechnology and her passion for transforming patient care perfectly align with our goal to bridge gaps in drug discovery and deliver meaningful, life-changing treatments. With a Ph.D. in Molecular and Human Genetics from Baylor College of Medicine, Dr. Agrawal has pioneered research in both diagnostics and therapeutics, leading to high-impact publications that reflect her dedication to precision medicine. Recently, she was awarded the Baylor College of Medicine Young Alumna Award, recognizing her remarkable contributions to healthcare innovation and her commitment to creating lasting impact in patient care. As the Co-Founder of Lazarus 3D, Dr. Agrawal transformed surgical preparation with patient-specific 3D models, helping surgeons achieve greater precision and safety. Through leadership in securing VC and non-dilutive funding from The National Institutes of Health, obtaining FDA clearance, and scaling operations, she has shown a clear commitment to advancing healthcare solutions, directly aligning with Keliomics’ mission. Dr. Agrawal’s expertise in #biotech innovation, commercialization, and team-building will drive Keliomics’ next chapter as we work to enable more efficient, reliable drug discovery. Join us in welcoming Dr. Agrawal to the team—together, we’re set to make a profound impact on patient care and the future of drug discovery! #PrecisionMedicine #Biotech #Exvivo #Pharma #Keliomics #Leadership #DrugDiscovery

Keliomics is hiring a Scientist Investigator! This leadership role will be responsible for completing the experimental work for our NCI-funded project in breast cancer (1R43CA291515-01). Successful applicants will hold a PhD and will have had experience generating breast cancer 3D models such as spheroids and/or organoids, and treating those models with clinically relevant therapeutics. To apply, please use this link: https://lnkd.in/gegJh3mC Oregon Bioscience Incubator and OTRADI Oregon Bioscience Association Oregon Nanoscience and Microtechnologies Institute Cara Turano Charla Triplett Liisa Bozinovic Smriti Agrawal, Ph.D.

Thank you Oregon Entrepreneurs Network and A.WordSmith for the thoughtful profile! Cara Turano

🚀 Exciting News! 🚀 We’re thrilled to announce that Dr. Allen Li has joined us as our new Scientific Director! Dr. Li brings a wealth of expertise, starting with his MD/PhD in Dermatology with 7 years' clinical experience before embarking on a distinguished career in research and drug development. His journey includes: 🔬 Postdoctoral Fellowship at the NIH’s National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 📚 Academic Contributions at Baylor College of Medicine and Oregon Health & Science University, where he co-led groundbreaking R01-funded projects on skin homeostasis and carcinogenesis 💊 Industry Leadership at Pfizer, Novartis, and PhaseRx, where he developed innovative preclinical models and led drug discovery programs from the discovery to clinical trials. Most recently, at TechnoDerma Medicines, Dr. Li spearheaded the development of two small molecule drugs into clinical trials, with a third ready for IND submission. His colleagues consistently praise his meticulous attention to detail, deep scientific knowledge, and approachable leadership style. We’re excited to see the incredible contributions Dr. Li will bring to our team! 👏 #Leadership #ScientificExcellence #DrugDiscovery #Dermatology #Innovation

We're #hiring a new Biospecimen Technician in Portland, Oregon Metropolitan Area. Apply today or share this post with your network.

We are hiring 2-3 biospecimen technicians to help collect surgical specimens. This is a wonderful and paid opportunity for pre-med and medical students in the Portland area to gain exposure to the clinical environment and to learn to obtain informed consent for research studies. Oregon Bioscience Incubator and OTRADI Oregon Bioscience Association Oregon Entrepreneurs Network Gabriela Rios-Sotelo, M.S., M.S. Cara Turano Charla Triplett Link to the application: https://lnkd.in/gBwJqJe7

We are delighted to share that Keliomics has received a $400,000 SBIR Phase 1 grant (1R43CA291515-01) from the National Cancer Institute (NCI) to validate our ex vivo breast tumors for fast, clinically relevant biopharmaceutical development. This funding supports our efforts to recreate disparities in patient responses to neoadjuvant chemotherapy in HR-/Her2+ breast cancer, as reported in clinical trials. The goal is to stand up the first ex vivo tumor platform that recreates clinical trial data. Huge congrats to our team including our collaborators Elizabeth Martin Matthew E Burow Van Barnes Katherine Hebert, PhD Delia Carlino at Tulane University School of Medicine, and a massive thank you to Linda Zane and the National Cancer Institute (NCI) for their support! https://lnkd.in/d6wdzVxQ #CancerResearch #BreastCancer #Her2BreastCancer #HealthDisparities **Research was supported by the National Cancer Institute of the National Institutes of Health under Award Number 1R43CA291515-01. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Keliomics is hiring a Scientific Director! Key Requirements: • PhD with 3 or more years postgraduate experience, preferably in a biotech, pharmaceutical, or CRO environment, or Masters/Bachelor’s Degree with commensurate combined experience • Prior experience in adipose tissue biology and/or expertise in some combination of: metabolism, oncology, or gene therapy • Experience leading and motivating teams • Proven track record in advancing multiple research projects simultaneously • Must have worked with human biospecimens and cells previously. Experience with surgical biospecimens preferred. https://lnkd.in/gVxYX82g

We had a great time with Senator Gorsek! Many thanks to Oregon Bioscience Incubator and OTRADI, Heather Ellis, Rene Miller, MS, Adrienne Klein for setting it up.

Congratulations Dr. Katherine Hebert, PhD!! Thank you for your groundbreaking work on triple negative breast cancer using our ex vivo human breast tissues. We're excited to follow your career! Congrats also to Professors Matthew E Burow and Elizabeth Martin for training and mentoring another excellent scientist. You're inspirational!